Quillivant XR 25 MG/5 ML susp 180ML
Ended Awarded
- Contract number
- SPE2DB25FVVZC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,803
Award facts
- Contract value 100% obligated
- $2,803.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,803.18 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), an extended-release liquid formulation of methylphenidate used in attention-deficit/hyperactivity disorder treatment. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that serves as the primary pharmaceutical supply vehicle for military healthcare systems worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering diverse pharmaceutical products and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, coupled with its expansive prime indefinite delivery contract, positions it as a key supplier for the military's pharmaceutical needs across multiple therapeutic domains including specialty medications, vaccines, and medical devices.
Quick answers
Who was awarded contract SPE2DB25FVVZC?
SPE2DB25FVVZC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FVVZC worth?
The government has obligated $2,803 on SPE2DB25FVVZC.
Is contract SPE2DB25FVVZC an order under another contract?
Yes. SPE2DB25FVVZC is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVVZC competed?
The extent of competition for SPE2DB25FVVZC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award